Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated September 22, 2020, titled "SPARC Licenses Commercialization Rights of ElepsiaTM XR to Tripoint Therapeutics".
Press Release Sep 22 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharma Advanced Research Co. Ltd. on 6ix
Earlier from Sun Pharma Advanced Research
- Press Release (Revised) Aug 19 2020
- Press Release Aug 19 2020
- Press Release Sun Pharma and SPARC enter into a worldwide license agreement for SCD 044May 28, 2020
- Sun Pharma Advanced Research and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension
Later from Sun Pharma Advanced Research
- Press Release Oct 14 2020
- Press Release May 14 2021
- AGM Speech 2020-21
- Press Release Nov 26 2021
- Press Release Dec 03 2021
Follow Sun Pharma Advanced Research into a list and get an email when it puts out news.
Follow Sun Pharma Advanced Research